Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: ACS Appl Mater Interfaces. 2021 Nov 30;13(49):58401–58410. doi: 10.1021/acsami.1c18941

Figure 5.

Figure 5.

Biodistribution and hepatic cellular distribution of the as-synthesized Ag2S-NPs. (A) Difference in silver content in major organs at 24 h after injection. Delta % ID = % ID of Ag2S-NPs from Synthesis B – % ID of Ag2S-NPs from Synthesis A. (B) Distribution of different Ag2S-NP formulations in hepatocytes and Kupffer cells. Error bars are SEM (n = 4). * indicates P < 0.05 (two-way ANOVA with Bonferroni’s multiple comparison test).